Parkinson's disease ␣-Synuclein PARK4 BAC transgenic mouse Serotonin transporter Decreased anxiety a b s t r a c t ␣-Synuclein (␣-syn), the main component of Lewy bodies, was identified as a genetic risk factor for idiopathic Parkinson's disease (PD). As a model for PD, we generated human ␣-syn bacterial artificial chromosome transgenic mice (BAC tg mice) harboring the entire human ␣-syn gene and its gene expression regulatory regions. The ␣-syn BAC tg mice manifested decreased anxiety-like behaviors which may reflect non-motor symptoms of early PD, and they exhibited increased SERT expression that may be responsible for decreased anxiety-like behaviors. Our ␣-syn BAC tg mice could be a valuable tool to evaluate ␣-syn gene dosage effects in vivo.
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Parkinson's disease (PD) is clinically characterized by not only motor symptoms, but various non-motor symptoms such as mood changes (Langston, 2006) . Pathologically, PD is characterized by the loss of catecholaminergic neurons and by the presence of Lewy bodies, mainly consisting of ␣-synuclein (Spillantini et al., 1997) . In addition, ␣-synuclein (␣-syn) gene multiplication (triplication; PARK4 and duplication) was found to cause autosomal dominant familial PD, which is quite similar to idiopathic PD both clinically and pathologically (Chartier-Harlin et al., 2004; Ibáñez et al., 2004; Singleton et al., 2003) .
Although the pathogenesis of PD remains unclear, genetic animal models are highly valuable for understanding the mechanisms of neurodegenerative disorders. Several ␣-syn transgenic (tg) mice * Corresponding author at: Department of Neurology, Kyoto University Graduate School of Medicine, 54 Kawahara-cho, Syogoin, Sakyo-ku, Kyoto 606-8507, Japan. using various promoters have been generated so far and have contributed to clarify the mechanisms of ␣-syn toxicity in vivo (Giasson et al., 2002; Lee et al., 2002; Masliah et al., 2000) . However, none of these models matched with all the salient features of human PD in terms of; 1) clinical symptoms of parkinsonism, 2) selective catecholaminergic neuronal loss and 3) fibrillar cytoplasmic inclusion formation. Therefore, there is a need to create more ideal mice models presenting these cardinal features of PD. Studies from ␣-syn multiplication patients show that augmented wild type ␣-syn expression alone can cause PD, when expressed by its native gene regulatory elements. Moreover, recent genome-wide association studies (GWAS) in PD identified the most critical SNP in the ␣-syn gene (Satake et al., 2009 ). These results imply that the ␣-syn gene is not only a causative gene for rare familial PD but important for the idiopathic PD, where ␣-syn expression might be augmented (Mizuta et al., 2006) . Based on these lines of evidence, we created genome-based ␣-syn BAC tg mice models for PD (Fig. 1A) . These mice are unique in that they harbor the entire human ␣-syn gene and its gene expression regulatory regions.
Recently, Kuo et al. (2010) created human A53T mutant ␣-syn PAC (P1 Artificial Chromosome) tg mice. These mice showed abundant ␣-syn aggregates with functional abnormalities in the enteric
